These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 7720160)

  • 21. Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neuromuscular disorders.
    Hopkins PM; Ellis FR; Halsall PJ
    Br J Anaesth; 1993 Apr; 70(4):397-401. PubMed ID: 8499197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of malignant hyperthermia susceptibility in low-risk subjects. An epidemiologic investigation of caffeine halothane contracture responses. The North American Malignant Hyperthermia Registry.
    Larach MG; Landis JR; Bunn JS; Diaz M
    Anesthesiology; 1992 Jan; 76(1):16-27. PubMed ID: 1729931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of North American and European malignant hyperthermia group halothane contracture testing protocols in swine.
    Fletcher JE; Conti PA; Rosenberg H
    Acta Anaesthesiol Scand; 1991 Aug; 35(6):483-7. PubMed ID: 1897341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevoflurane is less sensitive than halothane for in vitro detection of malignant hyperthermia susceptibility.
    Johannsen S; Klingler W; Schneiderbanger D; Heiderich S; Roewer N; Schuster F
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1161-6. PubMed ID: 23957432
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of salbutamol on the in vitro muscle response to caffeine and halothane in malignant hyperthermia.
    Bendixen D; Ording H
    Acta Anaesthesiol Scand; 1990 Nov; 34(8):658-61. PubMed ID: 2275327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diltiazem and nifedipine reduce the in vitro contracture response to halothane in malignant hyperthermia-susceptible muscle.
    Adnet PJ; Krivosic-Horber RM; Haudecoeur G; Reyford HG; Adamantidis MM; Dupuis BA
    Can J Anaesth; 1990 Jul; 37(5):556-9. PubMed ID: 2372858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-HT2 receptor antagonist-mediated inhibition of halothane-induced contractures in skeletal muscle specimens from malignant hyperthermia susceptible patients.
    Wappler F; Scholz J; Fiege M; Richter A; Steinfath M; Weisshorn R; Schulte am Esch J
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):376-81. PubMed ID: 10551274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of in vitro contracture tests with ryanodine and a combination of ryanodine with either halothane or caffeine: a comparative investigation in malignant hyperthermia.
    Bendahan D; Guis S; Monnier N; Kozak-Ribbens G; Lunardi J; Ghattas B; Mattei JP; Cozzone PJ
    Acta Anaesthesiol Scand; 2004 Sep; 48(8):1019-27. PubMed ID: 15315621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ryanodine contracture test may help diagnose susceptibility to malignant hyperthermia.
    Reuter DA; Anetseder M; Müller R; Roewer N; Hartung EJ
    Can J Anaesth; 2003; 50(7):643-8. PubMed ID: 12944436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of droperidol, haloperidol and ketamine on halothane, succinylcholine and caffeine contractures: implications for malignant hyperthermia.
    Fletcher JE; Rosenberg H; Lizzo FH
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):187-92. PubMed ID: 2728821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels.
    Weglinski MR; Wedel DJ; Engel AG
    Anesth Analg; 1997 May; 84(5):1038-41. PubMed ID: 9141928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xenon does not induce contracture in human malignant hyperthermia muscle.
    Baur CP; Klingler W; Jurkat-Rott K; Froeba G; Schoch E; Marx T; Georgieff M; Lehmann-Horn F
    Br J Anaesth; 2000 Nov; 85(5):712-6. PubMed ID: 11094586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
    Ginz HF; Girard T; Censier K; Urwyler A
    Eur J Anaesthesiol; 2004 Feb; 21(2):151-7. PubMed ID: 14977348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The action of ketamine on muscle contractile behavior. In vitro studies on the musculature of subjects susceptible to malignant hyperthermia].
    Hackl W; Winkler M; Mauritz W; Steinbereithner K
    Anaesthesist; 1989 Dec; 38(12):681-5. PubMed ID: 2619030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Bay K 8644 on the magnitude of isoflurane and halothane contracture of skeletal muscle from patients susceptible to malignant hyperthermia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyford H; Imbenotte M
    Anesthesiology; 1992 Apr; 76(4):544-9. PubMed ID: 1372490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome and malignant hyperthermia. In vitro comparison with halothane and caffeine contracture tests.
    Krivosic-Horber R; Adnet P; Guevart E; Theunynck D; Lestavel P
    Br J Anaesth; 1987 Dec; 59(12):1554-6. PubMed ID: 3426910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halothane-caffeine contracture testing in neuromuscular diseases.
    Heiman-Patterson TD; Rosenberg H; Fletcher JE; Tahmoush AJ
    Muscle Nerve; 1988 May; 11(5):453-7. PubMed ID: 3374516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Chloro-m-cresol test--a possible supplementary test for diagnosis of malignant hyperthermia susceptibility.
    Ording H; Glahn K; Gardi T; Fagerlund T; Bendixen D
    Acta Anaesthesiol Scand; 1997 Sep; 41(8):967-72. PubMed ID: 9311392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of the platelet-halothane nucleotide depletion test as a diagnostic or screening test for malignant hyperthermia.
    Britt BA; Scott EA
    Anesth Analg; 1986 Feb; 65(2):171-5. PubMed ID: 3942305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.